With the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on the brighter side for 2025. | With the fate ...

Mainland China's CSI 300 index jumped 2.34% by midday Singapore time, marking one of the strongest gains in the region.

Asia-Pacific markets mostly rose on Friday despite a plunge in all three benchmarks in the U.S. over the previous session ...

A representation of the country’s rapidly developing capability can be seen in the example of WuXi Biologics ... of manufacturing capacity for biologics. Similar signs of growth can be seen ...

Based on data reported through the CDP 2024 Assessment Questionnaire, WuXi Biologics achieved a score of "A" for Water Security, standing out among over 25,000 companies evaluated.

China health care companies received a significant reprieve in terms of geopolitical risks when the US Senate declined to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Our forward-looking statements are subject to risks relating to, among other things, the ability of our service offerings to compete effectively, our ability to meet timelines for the expansion of our ...